Many patients face significant challenges in immediate access to necessary treatment due to the upfront costs of medication, especially when reimbursement can take weeks or even months. This creates a financial strain, as most patients may face financial challenges to cover these costs immediately, even though they may have the means to pay back over time. Our cash-flow facilitation model is unique as it serves as an immediate financial bridge, allowing patients to access medications while they wait for reimbursement or to pay easily in smaller increments. This patient-centric solution also helps expand access to specialized treatment. Supported by our partners, pharmaceutical companies, and charities, the model is structured as a revolving fund that replenishes as patients and partners make installment payments, creating a sustainable support cycle for patients. To learn more about how the model is different from traditional financing solutions and how we manage a smooth operation, reach out to our program teams at axios@axiosint.com or contact us at https://lnkd.in/dX97AFZ6 #CashFlowFacility #OTA #AccesstoHealthcare
Axios International’s Post
More Relevant Posts
-
Recognizing the limitations of traditional fixed schemes for supporting patients' chronic conditions, Axios developed an innovative Tiered Cost-Sharing model to improve patient access and optimize the program sustainability and feasibility. What’s unique about this model is that patients understand the program's value and are able and willing to contribute based on their financial assessments. This enables them to follow through on their full treatment plans, which increases their financial sustainability without adding further burden to their situation. We make this a reality by using our novel and validated Patient Financial Eligibility Tool (PFET) to determine the help each patient needs and customize the Tiered-Cost Sharing model to suit them. It brings together patients and multi-payers - such as pharmaceutical companies, charities, governments, and insurers - to close the affordability gap, ensuring the financial sustainability of all partners and the program itself. To learn more about our novel tools and approach, contact us via https://lnkd.in/dX97AFZ6 or write to us at axios@axiosint.com #AxiosPAPs #TieredCostSharing #AccesstoHealthcare Omer Karfis Shahad Safaa Malak Ammar
To view or add a comment, sign in
-
Civica Rx, a non-profit organization founded in 2019, is making significant strides by investing in high-quality filling systems designed to reduce the cost of life-saving medications and improve availability. Their strong patient-first focus is globally recognized and is already having a significant impact on the industry. We are fortunate to have one of Civica Rx's founders, Martin Van Trieste, as the Chair of the Board for SmartSkin, who continues to drive forward his mission to improve quality culture and prioritize patient safety across manufacturing. Read more in the following article to learn about Civica's latest developments. https://lnkd.in/e3wUAsR6
To view or add a comment, sign in
-
From SPA blog series to advancements in the public prior authorization process, catch up on all the latest prior authorization developments here https://lnkd.in/g8-KD3Ti If you would like to know more about the initiative, get involved, or support this initiative, contact Denise Balch at info@simplifypriorauth.ca Follow us on LinkedIn to stay up to date on all things SPA! #SimplifyPriorAuthorization #SimplifyPriorAuth #SPA #ePA #PriorAuth #priorauthorization #patientaccess #electronicpriorauthorization #nonprofit #healthcare #canadianhealthcare #healthcaretrends #pharma #Canada
To view or add a comment, sign in
-
#ICYMI We recently announced Essential Pharma’s €900 million recapitalisation milestone. Watch the video below of our CEO Emma Johnson where she discusses how this transformative investment will strengthen our ability to deliver essential medicines to the patients who need them, wherever they are. Emma shares her excitement about continuing our successful partnership with Gyrus Capital, who have supported our transformation since 2019, as we welcome new partners to build on our diversified portfolio of established and rare disease medicines. #Fundraise #EssentialPharma #PharmaTeam
To view or add a comment, sign in
-
In honor of #PatientSafetyAwarenessWeek, we sat down with our Director of Pharmacy, Hyla Fritsch, to gather some valuable insight on the importance of following medication instructions and how to dispose of them properly. Read more on our blog: https://lnkd.in/eNpsAatn #medicationadherence #medicine #pharmacy #foundcare #directorofpharmacy #foundcareproud #blog #patientsafety #nonprofit #fqhc
To view or add a comment, sign in
-
At Axios International, our mission is to promote equitable and sustainable access to healthcare. Achieving financial sustainability is key to making this mission a reality, and here's how we do it. 🔗 Following a multi-stakeholder approach, we bring together pharmaceutical companies, healthcare professionals, governments, charities/NGOs, etc., to design and implement access strategies tailored to each partner's goals and capabilities, providing patients with access to healthcare. This helps us close healthcare access gaps and ensure affordability for patients. 🔗Using our Axios’ proprietary tools and various projects, we analyze patients' ability and willingness to pay, guiding the development of economically sustainable access programs. We design business cases that outline the potential for access initiatives in different countries, guiding our partners towards effective strategies. 🔗 We are with patients at every step of their treatment journey, ensuring they have the support they need as long as they are eligible to receive it. By managing the Patient Assistance Programs (PAPs), we help patients overcome obstacles, including financial challenges, through our Access to Treatment (ATT) solutions. To learn more about access to treatment solutions, visit: https://lnkd.in/dzGPUKDS #FinancialSustainability #AccesstoTreatment #AccesstoCare #PatientsFirst
To view or add a comment, sign in
-
Did you miss the last #CommunityPharmacy More Profit Roundtable? Here is a clip. I will put a link to the replay in the comments. #pharmacy #pharmacist #pharmacists #profit #removethemiddlemen
To view or add a comment, sign in
-
Proud to announce that Mermaid Bio GmbH and the CEO Ranja Salvamoser will be presenting at Meet the DONs Virtual Event on the 24th of October 2024. Sophisticated investors, decision makers and opportunities are all brought together by this special online experience. Due in part to COVID, we have welcomed over 1,500 virtual attendees since our launch in 2020. A true meeting place for CEOs, Founders, decision makers and sophisticated investors. Mermaid Bio’s Intrabodies represent a novel precision-medicine approach that can tackle notoriously difficult targets and is piloted directly to the tissue of interest to avoid damaging side effects. Intrabodies The power of antibodies and targeted drug delivery, wrapped in one. By pairing antibodies with intracellular delivery, Intrabodies bring the strength of antibodies into diseased cells, without damaging healthy tissues. Beyond giving patients new hope, our purpose is to restore their quality of life If you are a Founder, CEO or sophisticated investor register for free with this link - https://lnkd.in/eRMU3CEH Are you a healthcare business seeking funding if so, feel free to submit your opportunity to our network via this link - https://lnkd.in/ep8Bqsb8 #ceos #investors #fundraising
To view or add a comment, sign in
-
Medicine is important for human development so the degree to which a healthcare company enables access to medicine is an important indicator of quality, if you are a long term investor. Read here about a recent research partnership on affordable generics and biosimilar medicines.
We are delighted to have entered into a three-year research partnership with the Access to Medicine Foundation - an independent non-profit organisation that seeks to mobilise companies to expand access to their essential healthcare products in low- and middle-income countries. Find out about our partnership and the work we are supporting https://ow.ly/jAAW50SVK1S
Access to Medicine Foundation – Generics & Biosimilar Medicines Programme
stewartinvestors.com
To view or add a comment, sign in
-
In honor of #PatientSafetyAwarenessWeek, we sat down with our Director of Pharmacy, Hyla Fritsch, to gather some valuable insight on the importance of following medication instructions and how to dispose of them properly. Read more on our blog: https://lnkd.in/erJWAXS8 #medicationadherence #medicine #pharmacy #foundcare #directorofpharmacy #foundcareproud #blog #patientsafety #nonprofit #fqhc
To view or add a comment, sign in
22,624 followers
More from this author
-
Discussing On-Time Access (OTA) with Doctor in the House: ‘For Chronically Ill Patients, How Can They Get Financial Help?’
Axios International 3w -
The growing influence of Patient-Generated Health Data
Axios International 1mo -
On-Time Access: Making Access to Specialty Medications a Reality for Patients
Axios International 2mo